000			01241 a2200325 4500
005			20250512003019.0
264		0	_c19900213
008			199002s 0 0 eng d
022			_a0028-7091
040			_aNLM _beng _cNLM
100	1		_aGaraci, E
245	0	0	_aEnhanced immune response and antitumor immunity with combinations of biological response modifiers. _h[electronic resource]
260			_bBulletin of the New York Academy of Medicine _cJan 1989
300			_a111-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aImmunosuppression Therapy
650	0	4	_aInterferons _xadministration & dosage
650	0	4	_aInterleukin-2 _xadministration & dosage
650	0	4	_aKiller Cells, Natural _ximmunology
650	0	4	_aMice
650	0	4	_aNeoplasms, Experimental _ximmunology
650	0	4	_aThymalfasin
650	0	4	_aThymosin _xadministration & dosage
700	1		_aMastino, A
700	1		_aFavalli, C
773	0		_tBulletin of the New York Academy of Medicine _gvol. 65 _gno. 1 _gp. 111-9
999			_c2487531 _d2487531